Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICG Imaging in Pediatric Hemorrhagic Hydrocephalus
NCT06994949Phase 1Recruiting
- Start
- Jan 2025
- Primary completion
- Jan 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of indocyanine green in Post-hemorrhagic Hydrocephalus (PHH). Primary endpoints: Number of participants with continuing ventriculomegaly after CSF diversion and Number of participants with elevated ventriculomegaly after ETV/CPC. Started Jan 2025; status: recruiting.
02
Drugs
indocyanine green
03
Conditions
Post-hemorrhagic Hydrocephalus (PHH)
Beyond the preview
Go deeper on NCT06994949.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06994949.